{"doi":"10.1002/1873-3468.12919","title":"From yeast to humans – roles of the Kennedy pathway for phosphatidylcholine synthesis","abstract":"The major phospholipid present in most eukaryotic membranes is phosphatidylcholine (PC), comprising ~ 50% of phospholipid content. PC metabolic pathways are highly conserved from yeast to humans. The main pathway for the synthesis of PC is the Kennedy (CDP‐choline) pathway. In this pathway, choline is converted to phosphocholine by choline kinase, phosphocholine is metabolized to CDP‐choline by the rate‐determining enzyme for this pathway, CTP:phosphocholine cytidylyltransferase, and cholinephosphotransferase condenses CDP‐choline with diacylglycerol to produce PC. This Review discusses how PC synthesis via the Kennedy pathway is regulated, its role in cellular and biological processes, as well as diseases known to be associated with defects in PC synthesis. Finally, we present the first model for the making of a membrane via PC synthesis.","journal":"FEBS Letters","year":2018,"id":35435,"datarank":3.6403211911067483,"base_score":4.770684624465665,"endowment":4.770684624465665,"self_citation_contribution":0.7156026936698499,"citation_network_contribution":2.9247184974368987,"self_endowment_contribution":0.7156026936698499,"citer_contribution":2.9247184974368987,"corpus_percentile":null,"corpus_rank":null,"citation_count":117,"citer_count":104,"citers_with_citation_signal":83,"citers_with_endowment":83,"datacite_reuse_total":10,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":180397,"name":"Christopher R. McMaster","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":4.770684624465665,"endowment":4.770684624465665,"datacite_reuse_total":10,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"29178478","pmcid":null,"openalex_id":"https://openalex.org/W2768787369","authors":[],"funders":[{"funder_name":"Natural Sciences and Engineering Research Council of Canada","grant_id":"unidentified","title":"unidentified"},{"funder_name":"Natural Sciences and Engineering Research Council of Canada","grant_id":"","title":null}],"total_grants":2,"fwci":3.1607,"citation_percentile":0.92126824,"influential_citations":1,"citation_trend":[{"year":2018,"count":4},{"year":2019,"count":6},{"year":2020,"count":15},{"year":2021,"count":9},{"year":2022,"count":16},{"year":2023,"count":24},{"year":2024,"count":15},{"year":2025,"count":18},{"year":2026,"count":10}],"oa_status":"closed","license":"Wiley Online Library User Agreement","oa_locations":[{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1873-3468.12919","host_type":"BRONZE"},{"url":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1873-3468.12919","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/1873-3468.12919","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/full-xml/10.1002/1873-3468.12919","host_type":"publisher"},{"url":"https://febs.onlinelibrary.wiley.com/doi/pdf/10.1002/1873-3468.12919","host_type":"publisher"},{"url":"https://doi.org/10.1002/1873-3468.12919","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/29178478","host_type":"repository"},{"url":"https://febs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1873-3468.12919","host_type":""},{"url":"https://dx.doi.org/10.1002/1873-3468.12919","host_type":""}],"fields_of_study":["Biotin and Related Studies","Protein Kinase Regulation and GTPase Signaling","Metabolism and Genetic Disorders","Biology","Medicine","Chemistry","0301 basic medicine","0303 health sciences","03 medical and health sciences","Choline Kinase","Cytidine Diphosphate Choline","Humans","Phosphatidylcholines","Saccharomyces cerevisiae","Saccharomyces cerevisiae Proteins"],"mesh_terms":["Choline Kinase","Cytidine Diphosphate Choline","Humans","Phosphatidylcholines","Saccharomyces cerevisiae","Saccharomyces cerevisiae Proteins"],"keywords":["Phosphocholine","Choline kinase","Choline","Phosphatidylcholine","Diacylglycerol kinase","Phospholipid","Biochemistry","Phosphorylcholine","Biosynthesis","Enzyme","Yeast","Chemistry","Mutant","Metabolic pathway","Cell biology","Membrane","Biology","Protein kinase C","Gene","Cytidine Diphosphate Choline","Saccharomyces cerevisiae Proteins","Phosphatidylcholines","Humans","Saccharomyces cerevisiae"],"sdg_mappings":[],"linked_datasets":[{"doi":"10.6084/m9.figshare.26677625.v1","title":"Additional file 1 of Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26677625","title":"Additional file 1 of Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.22605757","title":"Additional file 3 of Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.22605760","title":"Additional file 4 of Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.22605757.v1","title":"Additional file 3 of Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.22605754","title":"Additional file 2 of Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.22605751","title":"Additional file 1 of Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.22605754.v1","title":"Additional file 2 of Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.22605751.v1","title":"Additional file 1 of Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.22605760.v1","title":"Additional file 4 of Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice","publisher":"figshare","resource_type":"Image"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-10T03:56:55.504866Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}